Form 4 for LAB STANDARD BIOTOOLS INC.
Accepted 2025-08-05 00:00:00 ET · period of report 2025-08-01 · accession 0000950170-25-103300 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-05 | 2025-08-01 | LAB | Kim Hanjoon Alex | CFO | A - Grant | $0.00 | +1.50M | 2.44M | +159% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-01 | A | A | 1,500,000 | $0.00 | 2,440,564 | D | — | — | (F1) Represents Restricted Stock Units ("RSUs") that vest as to 40% of the RSUs on July 20, 2026, with the remaining 60% of the RSUs vesting on July 20, 2027, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting. (F2) Includes an aggregate of 12,861 shares of common stock previously acquired by the Reporting Person under the Issuer's Employee Stock Purchase Plan. |